PARKHOSPS - Park Medi World
📢 Recent Corporate Announcements
Park Medi World Limited has officially launched its multi-super specialty hospital in Panchkula, strengthening its footprint in the Tricity region alongside its Mohali expansion. The group currently operates 16 hospitals with 3,960 beds and is North India's second-largest hospital chain. The company is executing an aggressive growth plan to add 1,500 beds through five new hospitals and existing facility expansions. This strategic move aims to reach a total capacity of 5,460 beds by March 2028, focusing on high-margin tertiary and quaternary care services.
- Launched a new multi-super specialty hospital in Panchkula, targeting a combined Tricity capacity of 850 beds.
- Currently operates 16 hospitals with a total capacity of 3,960 beds across North India.
- Planned addition of 1,500 beds through 5 new hospitals and existing facility expansions.
- Projected total bed capacity to reach 5,460 beds by March 2028.
- Focus on high-acuity care including oncology, neurosciences, and robotic-assisted procedures.
Park Medi World Limited has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by its Registrar and Share Transfer Agent, Kfin Technologies Limited, covers the quarter ended March 31, 2026. It confirms that all securities dematerialized or rematerialized during this period have been appropriately reported to the stock exchanges. This is a standard procedural filing required for all listed entities to maintain transparency in shareholding records.
- Compliance certificate submitted for the quarter ended March 31, 2026.
- Issued by Kfin Technologies Limited, the company's Registrar and Share Transfer Agent.
- Confirms adherence to SEBI (Depositories and Participants) Regulations, 2018.
- The filing was submitted to both BSE and NSE on April 02, 2026.
Park Medi World Limited (PARKHOSPS) has announced the closure of its trading window for designated persons starting April 1, 2026. This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the declaration of audited financial results. The closure pertains to the financial results for the quarter and full year ending March 31, 2026. The window will remain shut until 48 hours after the results are officially disclosed to the stock exchanges.
- Trading window closure effective from Wednesday, April 1, 2026.
- Closure is related to the Audited Standalone and Consolidated Financial Results for FY 2025-26.
- The window will reopen 48 hours after the financial results are announced.
- The specific date for the Board Meeting to approve the results will be communicated at a later date.
Park Medi World Limited has announced a minor rescheduling of its new hospital launch in Panchkula. The facility, which was previously slated to open on March 29, 2026, will now be inaugurated on April 10, 2026. This 12-day delay is a routine operational update and is unlikely to have a material impact on the company's long-term financial performance. Investors should track the commencement of services at this new location as part of the company's growth strategy.
- Panchkula Hospital launch date moved from March 29, 2026, to April 10, 2026.
- The postponement represents a minor 12-day delay in the expansion timeline.
- Disclosure submitted under Regulation 30 of SEBI Listing Regulations.
- Follows a previous project update provided on March 10, 2026.
Park Medi World Limited has successfully completed the acquisition of a 100% stake in SVPD Healthcare Private Limited as of March 20, 2026. This follows the previous acquisition of K P S Wellness Private Limited, collectively giving the company full control over the KP Institute of Medical Sciences (KPIMS) in Agra. KPIMS is a significant healthcare facility with a 360-bed capacity. This strategic move consolidates the company's expansion into the Agra market and adds substantial operational capacity to its portfolio.
- Completed 100% acquisition of SVPD Healthcare Private Limited on March 20, 2026
- SVPD Healthcare has now become a wholly owned subsidiary of Park Medi World
- Finalizes the takeover of the 360-bed KP Institute of Medical Sciences (KPIMS) in Agra
- Follows the successful 100% acquisition of K P S Wellness Private Limited completed in January 2026
Park Medi World Limited is significantly expanding its footprint in the Tricity region by launching a new multi-super specialty hospital in Panchkula and expanding its Mohali facility. The Panchkula hospital, expandable to 350 beds, will commence operations on March 29, 2026. Additionally, the company will add 150 beds to its existing 350-bed Mohali facility with an investment of Rs. 40 crores funded via internal accruals. These moves will establish the company as the largest private healthcare provider in the region with a total of 850 beds.
- New Panchkula hospital with up to 350 beds to start operations on March 29, 2026.
- Expansion of Mohali facility by 150 beds (total 500) to be completed within 18 months.
- Investment of approximately Rs. 40 crores for Mohali expansion funded through internal accruals.
- Consolidated Tricity capacity to reach 850 beds, creating the region's largest private network.
- Group-wide target to reach 5,460 beds by March 2028 from the current 3,610 beds.
Park Medi World is significantly expanding its footprint in the Tricity region by launching a new multispecialty hospital in Panchkula on March 29, 2026. Additionally, the board has approved a 150-bed expansion at its Mohali facility, which currently operates at 73% capacity, bringing the total regional capacity to 850 beds. The Mohali expansion involves an investment of approximately Rs. 40 crores, which will be entirely funded through internal accruals. This strategic move is expected to make the company the largest private healthcare network in the Tricity area, focusing on high-margin tertiary and quaternary care.
- Launch of Panchkula Hospital (up to 350 beds) scheduled for March 29, 2026
- Expansion of Mohali Hospital by 150 beds, increasing its total capacity from 350 to 500 beds
- Investment of Rs. 40 crores for Mohali expansion to be funded via internal accruals over 18 months
- Consolidated Tricity capacity to reach 850 beds, establishing regional market leadership
- Group-wide target to reach 5,460 beds by March 2028 from the current 3,610 beds
Park Medi World is significantly scaling its presence in the Tricity region by launching a new multispecialty hospital in Panchkula on March 29, 2026. The board also approved a 150-bed expansion at its Mohali subsidiary, increasing its capacity from 350 to 500 beds with a Rs. 40 crore investment. These developments will bring the company's total regional capacity to 850 beds, establishing it as the largest private healthcare network in the area. The expansion is strategically funded through internal accruals and targets high-margin quaternary care services.
- New Panchkula hospital to commence operations on March 29, 2026, with capacity up to 350 beds.
- Approved 150-bed expansion at Mohali facility, increasing total beds there to 500 within 18 months.
- Consolidated Tricity region capacity to reach 850 beds, establishing regional market leadership.
- Expansion cost of Rs. 40 crores for the Mohali unit to be funded entirely through internal accruals.
- Strategic focus on high-acuity specialties including Oncology, Neurosciences, and Robotic Surgeries.
Park Medi World Limited (PARKHOSPS) has announced a virtual meeting with analysts and institutional investors scheduled for March 14, 2026. The session is organized by Divitiae Investments and will commence at 11:30 a.m. The company has explicitly stated that no unpublished price-sensitive information will be shared during the interaction. This is a standard investor relations activity aimed at maintaining transparency with the market.
- Virtual investor meeting scheduled for March 14, 2026, at 11:30 a.m.
- Session organized by Divitiae Investments for institutional investors and analysts.
- Disclosure made in compliance with Regulation 30 of SEBI Listing Regulations.
- Management confirms no unpublished price-sensitive information (UPSI) will be discussed.
Park Medi World Limited (PARKHOSPS) has scheduled an interaction with analysts and institutional investors on March 09, 2026. The engagement will consist of a physical facility visit and include both group and one-on-one meeting formats. The company has explicitly stated that no unpublished price-sensitive information (UPSI) will be discussed during these sessions. This move is part of the company's routine investor relations activities to provide transparency regarding its operational infrastructure.
- Investor and analyst meet scheduled for March 09, 2026.
- The event includes a physical facility visit to provide operational insights.
- Interaction format covers both group and one-on-one meetings with management.
- Disclosure submitted under Regulation 30 of SEBI Listing Regulations.
- Company confirms no unpublished price-sensitive information will be shared.
Park Medi World Limited (PARKHOSPS) has announced its participation in the Arihant Bharat Connect Conference – Rising Stars 2026. The meeting is scheduled for March 11, 2026, and will be conducted in a virtual group format. This interaction is part of the company's standard engagement with institutional investors and analysts. The management has explicitly stated that no unpublished price-sensitive information will be shared during the session.
- Participation in Arihant Bharat Connect Conference – Rising Stars 2026 scheduled for March 11, 2026.
- The meeting will be held via virtual mode in a group setting.
- Organized by Arihant Capital to connect 'Rising Stars' with institutional investors.
- Management confirms no unpublished price-sensitive information (UPSI) will be discussed.
Park Medi World Limited has announced a timeline extension for the final phase of its acquisition of KP Institute of Medical Sciences (KPIMS), a 360-bed hospital in Agra. While the 100% stake acquisition of KPS Wellness Private Limited was completed in January 2026, the acquisition of the second target entity, SVPD Healthcare Private Limited, is now expected by March 31, 2026. This represents a one-month extension from the previous indicative deadline of February 28, 2026. The overall deal remains intact as part of the company's strategic expansion in the healthcare sector.
- Acquisition of KP Institute of Medical Sciences (KPIMS) involves a 360-bed facility in Agra
- 100% stake in KPS Wellness Private Limited already successfully acquired on January 30, 2026
- Completion deadline for 100% stake in SVPD Healthcare Private Limited extended to March 31, 2026
- The acquisition was originally approved by the Board on December 19, 2025
Park Medi World Limited (PARKHOSPS) has announced a two-day investor roadshow scheduled for February 16 and 17, 2026, in Mumbai. The company's management will participate in physical one-on-one or group meetings with various analysts and institutional investors. This initiative is part of the company's regular investor relations activities to maintain market engagement. The company has explicitly stated that no unpublished price sensitive information will be shared during these sessions.
- Roadshow scheduled for February 16 and 17, 2026, in Mumbai.
- Meetings will be conducted in physical mode, including one-on-one and group formats.
- Disclosure filed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Management confirms that no unpublished price sensitive information (UPSI) will be discussed during the event.
Park Medi World Limited (PARKHOSPS) has announced its participation in the Hospitals & Diagnostics conference organized by DAM Capital. The event is scheduled for March 23, 2026, and will be held physically in Mumbai. The management will engage in both one-to-one and group meetings with institutional investors and analysts. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be discussed during these interactions.
- Participation in DAM Capital Hospitals & Diagnostics conference on March 23, 2026
- Meeting format includes both one-to-one and group sessions with institutional investors
- Physical meeting venue set for Mumbai as per SEBI Regulation 30 disclosures
- Management confirms no unpublished price sensitive information will be shared
- Disclosure filed with BSE and NSE on February 9, 2026
Park Medi World Limited (PARKHOSPS) has scheduled a meeting with analysts and institutional investors for February 18, 2026. The management will participate in the 'Corporate Conference 2026: Decoding Growth Strategies' organized by Dolat Capital in Mumbai. This physical conference is a routine engagement to discuss the company's growth outlook with the investment community. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during the event.
- Investor conference scheduled for February 18, 2026, in Mumbai.
- Event organized by Dolat Capital titled 'Decoding Growth Strategies'.
- Management participation will be in a physical conference format.
- Disclosure made in compliance with Regulation 30 of SEBI Listing Regulations.
Financial Performance
Revenue Growth by Segment
Total operating income grew 13.16% YoY to INR 1,393 Cr in fiscal 2025 from INR 1,231 Cr in fiscal 2024. Revenue is well-diversified across specialties, with no single specialty accounting for more than 16% of total revenue in fiscal 2025.
Geographic Revenue Split
100% of revenue is generated from North India, with a presence in key cities including Delhi, Gurgaon, Noida, Mohali, Jaipur, Behror, Faridabad, Panipat, Karnal, Sonipat, Ambala, Patiala, and Bathinda.
Profitability Margins
Operating margins declined from 31% in fiscal 2023 to 26.8% in fiscal 2025 due to moderate occupancy in recently acquired hospitals. Reported PAT margin improved from 12.14% in fiscal 2024 to 15.45% in fiscal 2025.
EBITDA Margin
Operating margin stood at 26.8% in fiscal 2025, a decrease from 31% in fiscal 2023. This decline is attributed to the low absorption of fixed costs in new acquisitions in Patiala and Mohali and changes in accounting to IND AS.
Capital Expenditure
Planned capital expenditure of INR 150-200 Cr for fiscal 2026 to fund greenfield projects in Panchkula and brownfield expansions in Narela and Kanpur.
Credit Rating & Borrowing
Credit rating reaffirmed at 'Crisil A+/Stable' in November 2025. Sanctioned bank limits of INR 362 Cr were utilized at 25% on average through June 2025.
Operational Drivers
Raw Materials
Medical consumables, surgical implants, and pharmaceutical drugs (specific % of total cost not disclosed).
Capacity Expansion
Current capacity of 3,250 beds across 14 hospitals; planned expansion to reach 5,260 beds by March 2028 through the addition of 2,010 beds via 7 hospitals under execution.
Manufacturing Efficiency
Average Revenue Per Occupied Bed (ARPOB) is healthy at approximately INR 26,000. Occupancy levels in recently acquired units remain a key monitorable for efficiency.
Strategic Growth
Expected Growth Rate
22%
Growth Strategy
Growth will be achieved through a cluster-based model, expanding bed capacity from 3,250 to 5,260 by March 2028. This includes integrating 7 hospitals currently under execution and acquiring brownfield projects like the 250-bed Krishna Super-speciality Hospital for INR 40 Cr. Growth is also driven by improving occupancy in recently acquired units in Patiala and Mohali and maintaining a healthy ARPOB of INR 26,000.
Products & Services
Super-specialty clinical services including Cardiology, Neurology, Oncology, Orthopaedics, Gastroenterology, Critical Care, Nephrology, and Women & Child Health.
Brand Portfolio
Park Group of Hospitals, Park Medi World.
New Products/Services
Integration of 7 new hospitals adding 2,010 beds by 2028; acquisition of Krishna Super-speciality Hospital (250 beds) in Bathinda.
Market Expansion
Targeting North India regions including Panchkula, Narela, and Kanpur with a timeline to reach 5,260 beds by March 2028.
Market Share & Ranking
Ranked as North India’s 2nd largest hospital chain.
External Factors
Industry Trends
The North Indian healthcare market is shifting towards large multi-specialty chains that can offer metropolitan-grade care in regional hubs. Park Group is positioning itself to capture this by expanding into cities like Bathinda and Panchkula, leveraging technology-enabled ecosystems to improve clinical outcomes.
Competitive Landscape
Operates as the 2nd largest chain in North India, competing with other multi-specialty providers in the Delhi-NCR and Punjab regions.
Competitive Moat
The group's moat is its 30-year brand recall and the promoters' proven ability to turn brownfield acquisitions profitable quickly. This is sustainable because high capital intensity and specialized talent requirements create significant entry barriers, while the group's established presence in 14 locations provides a strong referral network.
Consumer Behavior
Increasing consumer demand for metropolitan-grade healthcare locally in regional and rural districts like Bathinda and Patiala.
Regulatory & Governance
Industry Regulations
Operations are governed by medical waste pollution norms, healthcare facility standards, and pricing regulations on essential medical supplies. Compliance is critical to avoid operational disruptions in its 14 multi-specialty hospitals.
Risk Analysis
Key Uncertainties
The primary risk is the timely stabilization of the 2,010 new beds planned by 2028. If occupancy remains moderate, the operating margin could fall below 23%, which would reduce cash accruals below the expected INR 300-320 Cr level.
Geographic Concentration Risk
100% of revenue is derived from North India (Delhi, Haryana, Punjab, Rajasthan), making the group sensitive to regional economic shifts or regulatory changes in these specific states.
Technology Obsolescence Risk
The group is mitigating technology risks by investing in modern medical infrastructure, including modular OTs and automated laboratories, to ensure clinical excellence and maintain its INR 26,000 ARPOB.